Hims & Hers Health Inc Ordinary Shares - Class A (HIMS)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell

$28.67

Buy

$28.77

arrow-down$-0.08 (-0.28%)

Prices updated at 30 Sep 2026, 00:58 EDT
| Prices minimum 15 mins delay
|
Prices in USD
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include g ...
S&P 500
arrow-down-0.17%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.

Profit margins

Valuation

Profit margins data table

Year
chevron-l-regular
chevron-r-regular
Gross margin (%)
202573.84
202479.45
202381.99
202277.57
202175.22
202073.58
201954.03

Valuation data table

Year
chevron-l-regular
chevron-r-regular
Price / Sales
20262.76
20253.72
20244.43
20232.34
20223.00
20214.16
Price/Forward earnings (YTD)
74.63

Returns

Debt profile

Returns data table

Year
chevron-l-regular
chevron-r-regular
Return on assets (%)
20258.97
202421.94
2023-5.83
2022-16.69
2021-39.93
2020-18.99
2019-99.99

Debt profile data table

YearFinancial leverage
20253.98
20241.48
20231.28
20221.18
20211.26
2020-
2019-
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.